SOUTH ASIAN CONSENSUS GUIDELINE: USE OF GLP-1 ANALOGUE THERAPY IN DIABETES DURING RAMADAN

South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan

South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan

Blog Article

Ramadan is a lunar based month, during which Muslims across the world observe the ritual fast.This provides a challenge not only to the diabetic patient who wishes to observe the fast but also to the health care professional managing his diabetes.The challenge Engine Air Box Pre-Filter is to use therapies which are effective in maintaining good glycemic control and at the same time have a low propensity to cause hypoglycemia during the several hours of no calorie intake.

The GLP-1 analogues are unique agents which are effective in providing glycemic reduction with a very low risk of hypoglycemia and hence find an important hookah decor place in the management of diabetes during Ramadan.This Consensus Statement describes the pre-Ramadan assessment, planning, prescription and management and monitoring of patients who are on GLP-1 analogues, with or without other antidiabetic therapies.

Report this page